Sensitivity of PCR assays for murine gammaretroviruses and mouse contamination in human blood samples.
Lee, Li Ling, Lin, Lin, Bell, David S et al. · PloS one · 2012 · DOI
Quick Summary
Researchers tested blood samples from ME/CFS patients and healthy people to see if they contained a virus called MLV (murine leukemia virus). They used sensitive detection methods to look for viral genetic material, but found that when they did detect it, they couldn't be sure it actually came from the patient's blood rather than from contamination during testing.
Why It Matters
This study addresses a crucial controversy in ME/CFS research regarding whether MLV-related viruses are genuinely present in patient blood. Establishing whether such viruses are truly associated with ME/CFS requires reliable detection methods that can distinguish real viral sequences from laboratory contamination—a problem this study highlights.
Observed Findings
PCR assays designed to detect MLV-related gag sequences showed extremely high sensitivity
MLV-like sequences were identified following PCR amplification from human DNA preparations
Mouse DNA contamination was detected in some samples, suggesting potential laboratory contamination
The researchers could not definitively determine whether detected sequences originated from blood samples or from contaminants
Multiple experimental approaches (whole blood, PBMCs, cultured PBMCs, and plasma) were tested with similar uncertainty regarding sequence origin
Inferred Conclusions
Laboratory contamination is a significant confounding factor in PCR-based detection of MLV sequences in human samples
Higher sensitivity in detection assays does not necessarily improve the ability to determine the true origin of detected sequences
Methodological refinements are needed to reliably distinguish genuine viral sequences in patient blood from contamination artifacts
Remaining Questions
What contamination source(s) are responsible for the detected MLV-like sequences?
Can improved sample handling and analysis protocols eliminate contamination while maintaining detection sensitivity?
What This Study Does Not Prove
This study does not prove that MLV is absent from ME/CFS patients' blood, nor does it prove that MLV causes or contributes to ME/CFS. The findings demonstrate methodological challenges in detecting these sequences but do not resolve whether MLV is actually present in patient samples; the detection of sequences cannot be conclusively attributed to patient blood due to contamination concerns.